These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 12918765)
1. Efficacy of corticosteroids and cyclosporin in the treatment of retinal vasculitis in patients with Behçet's disease. Ermakova NA Adv Exp Med Biol; 2003; 528():563-5. PubMed ID: 12918765 [No Abstract] [Full Text] [Related]
2. High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results. Davatchi F; Shahram F; Chams H; Jamshidi AR; Nadji A; Chams C; Akbarian M; Gharibdoost F Adv Exp Med Biol; 2003; 528():579-84. PubMed ID: 12918769 [No Abstract] [Full Text] [Related]
3. Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report. Shahram F; Davatchi F; Chams H; Nadji A; Jamshidi A; Akbarian M; Gharibdoost F Adv Exp Med Biol; 2003; 528():571-3. PubMed ID: 12918767 [No Abstract] [Full Text] [Related]
4. Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment. Deuter CM; Kötter I; Günaydin I; Zierhut M; Stübiger N Adv Exp Med Biol; 2003; 528():525-8. PubMed ID: 12918756 [No Abstract] [Full Text] [Related]
5. Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study). Davatchi F; Shams H; Rezaipoor M; Sadeghi-Abdollahi B; Shahram F; Nadji A; Chams-Davatchi C; Akhlaghi M; Faezi T; Naderi N Int J Rheum Dis; 2010 Aug; 13(3):246-52. PubMed ID: 20704622 [TBL] [Abstract][Full Text] [Related]
7. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years. Davatchi F; Sadeghi Abdollahi B; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Faezi T; Akhlaghi M; Ghodsi Z; Ashofteh F; Mohtasham N Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325 [TBL] [Abstract][Full Text] [Related]
8. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease. Tabbara KF; Al-Hemidan AI Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351 [TBL] [Abstract][Full Text] [Related]
9. Occlusive retinal vasculitis secondary to Behçet's disease. Tien PT; Lin HJ; Chen WL; Lin CJ; Lin JM; Tsai YY Postgrad Med J; 2017 Feb; 93(1096):106. PubMed ID: 27489374 [No Abstract] [Full Text] [Related]
10. Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years. Davatchi F; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Sadeghi Abdollahi B; Faezi T; Akhlaghi M; Ashofteh F Int J Rheum Dis; 2013 Oct; 16(5):568-77. PubMed ID: 24164845 [TBL] [Abstract][Full Text] [Related]
12. [Comparative evaluation of the effectiveness of corticosteroids and cytostatics in treating retinal angiitis in Behcet's disease]. Ermakova NA Vestn Oftalmol; 2002; 118(5):32-5. PubMed ID: 12532744 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Gül A; Tugal-Tutkun I; Dinarello CA; Reznikov L; Esen BA; Mirza A; Scannon P; Solinger A Ann Rheum Dis; 2012 Apr; 71(4):563-6. PubMed ID: 22084392 [TBL] [Abstract][Full Text] [Related]
14. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study. Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895 [TBL] [Abstract][Full Text] [Related]
15. Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin. Hayasaka S; Kawamoto K; Noda S; Kodama T Ophthalmologica; 1994; 208(4):210-3. PubMed ID: 7970549 [TBL] [Abstract][Full Text] [Related]
16. Effect of intravitreal methotrexate and aqueous humor cytokine levels in refractory retinal vasculitis in Behcet disease. Bae JH; Lee SC Retina; 2012 Jul; 32(7):1395-402. PubMed ID: 22012204 [TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of infliximab in the treatment of Behçet's disease. Capella MJ; Foster CS Ocul Immunol Inflamm; 2012 Jun; 20(3):198-202. PubMed ID: 22486265 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial. Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571 [TBL] [Abstract][Full Text] [Related]
19. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population. Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486 [TBL] [Abstract][Full Text] [Related]